Mission Bio

Yan Zhang, Ph.D., CEO

Oct. 13 | 4:30pm | AVROBIO Ballroom

San Francisco, CA


In-person Presentation

Mission Bio unlocks the ground truth of cancer through response, relapse, and remission with its Tapestri Platform, powered by single-cell multi-omics. As the first and only to analyze genotype and phenotype simultaneously in single cells, the Tapestri Platform can help unravel the inherent complexity of cancer. Discover how Tapestri enables accurate characterization of your cell and gene therapy candidates for safer and more effective therapeutic strategies. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts. 


By using this website you agree to accept our Privacy Policy and Terms & Conditions